BiotechTube
Home/Allinaire Therapeutics/Douglas W.P. Hay, PhD
DW

Douglas W.P. Hay, PhD

CEO and CSO

Allinaire Therapeutics

Therapeutic Areas

Pulmonary Arterial HypertensionCardiopulmonary Diseases

Allinaire Therapeutics Pipeline

DrugIndicationPhase
Anti-EMAP II monoclonal antibodyPulmonary Arterial Hypertension (PAH)Pre-clinical

Leadership Team at Allinaire Therapeutics

CP
Christa Pawlowski, PhD
COO
IP
Irina Petrache, MD
Scientific Co-founder
MC
Matthias Clauss, PhD
Scientific Co-founder
SJ
Satish Jindal, PhD
Chairman of the Board, Partner at Advent Life Sciences
View full Allinaire Therapeutics profile